DeepZhi and LizhiHealth Launch AI-Powered Emergency Rapid Testing Kit at Autumn CMEF to Expand Point-of-Care Applications

This October, the 85th China International Medical Equipment Fair (CMEF), themed “Innovative Technology, Leading the Future with Intelligence,” was held at the Shenzhen World Exhibition & Convention Center.

The conference showcased advanced medical equipment from across China and around the world. A notable trend is that device digitalization has become one of the most dynamic areas in the current exploration of healthcare digitalization pathways.

As an important auxiliary decision-making tool for enhancing the clinical and imaging diagnostic value of healthcare, as well as improving efficiency, the application frequency of artificial intelligence (AI) naturally remains high. At the conference’s imaging zone, numerous AI imaging companies arrived with their own artificial intelligence solutions.

Shanghai Shenzhi Information Technology Co., Ltd. (hereinafter referred to as “Shenzhi Technology”), which focuses on the research and development of intelligent medical imaging devices and digital healthcare services, also participated in this conference.At the conference,The company has partnered with Lizhijian Biotechnology to launch an AI-powered rapid emergency testing kit, which includes their newly developed handheld color Doppler ultrasound diagnostic device.

Founded in 2018, the company has been dedicated to empowering innovative mobile healthcare scenarios through ultrasound AI research, compact imaging devices, and remote diagnostic platforms. Despite its relative youth, it is one of the few ultrasound artificial intelligence companies worldwide that possess proprietary underlying algorithms, with its “handheld ultrasound” device remaining its flagship product.

Shenzhi Technology’s focus on “handheld ultrasound” and its positioning in ultrasound AI and compact imaging equipment stem from its recognition of the market potential in ultrasound and China’s primary healthcare sector.

On one hand, China’s ultrasound market is a high-volume sector with 2 billion annual examinations, yet there are only 120,000 registered specialist physicians, resulting in a significant supply-demand gap.

On the other hand, the standardization of ultrasound examinations remains an unresolved issue. Primary healthcare institutions also face significant challenges, including shortages of medical resources, inadequate clinical capabilities, and prolonged training periods for ultrasound operation.

In the face of this package of issues,Shenzhi Technology aims to reduce the cost and accessibility barriers of equipment applications through continuous development of intelligent hardware and software, empowering grassroots healthcare with “technology enablement” to further popularize precision medicine.Transform ultrasound diagnosis from experience-driven to intelligence-driven, and evolve ultrasound equipment from “bulky” to “mobile,” “compact,” and “lightweight.”

Nowadays, Shenzhi Technology not only continues to explore technological advancements to further simplify testing processes, lower the barrier to equipment usage, and expand the application scope of its products, but alsoBegin exploring more forms of product implementation and broaden its application scenarios., enabling the pain points in scenarios that traditional desktop ultrasound equipment fails to address to be resolved by handheld ultrasound, a portable, compact, all-in-one device.

Take, for example, the AI-powered rapid emergency testing kit jointly launched by Shenzhi Technology and Lizhijian Biotechnology., although this handheld color Doppler ultrasound diagnostic device is only the size of a mobile phone, it can meet the composite needs such as emergency ultrasound detection in special areas and under complex conditions.

According to relevant staff members,, this handheld color Doppler ultrasound diagnostic system simplifies the ultrasound diagnostic process to a certain extent. It not only improves diagnostic accuracy but also lowers the threshold for performing ultrasound diagnostics, thereby extending the benefits of medical convenience to more regions. Additionally, it features rapid scanning and real-time image transmission.

With its portable ultrasound devices, ease of operation, and precise diagnostic results, the Shenzhen Shenzhi Technology booth attracted numerous attendees and investors.

At the exhibition, Shenzhi Technology not only provided attendees with complimentary real-time screening services—allowing them to experience portable ultrasound devices capable of completing scans in 2 minutes and generating reports within 10 minutes—but also offered a detailed explanation of its comprehensive product portfolio strategy centered on AI-powered mobile medical imaging.

This August, the Health Commission of Liuzhi Special District in Liupanshui City partnered with Shenzhi Technology to launch the “Rural Healthcare Revitalization: Caring for Elderly Health—Public Welfare Stroke Screening Campaign.” By leveraging AI-assisted diagnosis combined with remote consultations from hundreds of physicians, Shenzhi Technology improved the detection rate of carotid plaques, thereby further promoting the equitable distribution of high-quality medical resources.

As the only ultrasound AI company in China currently possessing proprietary foundational algorithms, Shenzhen Technology’s strategic positioning has enabled it to establish collaborations with numerous leading medical device manufacturers, Meinian Onehealth, large Grade A tertiary hospitals in Shanghai, top-tier experts, and teaching hospitals.

As product networks, commercial channels, and technological pathways continue to mature, companies are not only strategizing for the existing installed base of ultrasound systems but also expanding into future clinical departments and primary care clinics, enabling a broader range of medical institutions to equip themselves with pocket-sized ultrasound devices. Currently, Shanghai Shenzhi Information Technology Co., Ltd. is seeing substantial monthly growth in its grassroots market penetration. Moving forward, the company will continue to strengthen its product deployment efforts to broaden its coverage.

It is evident from the Autumn CMEF that, after four to five years of development, artificial intelligence (AI) in medical imaging has become a prominent application scenario within the broader field of healthcare AI. Many medical imaging companies have integrated AI as a key enabling technology into their device applications. The incorporation of AI has also led to improvements in the speed of disease assessment, the efficiency of medical diagnosis, and the allocation of healthcare resources.

After passing through the "peak of inflated expectations," artificial intelligence technology has matured in its development. In the wake of this surge, a head effect is beginning to emerge.

In August this year, Gartner released the “2021 Hype Cycle for Emerging Technologies,” and believes that from now until 2022,Investment in artificial intelligence across the entire industry will grow at a moderate to rapid pace, with leading companies leveraging technological superiority to build trust and create new growth opportunities.

Shenzhi Technology holds distinct advantages as an AI medical imaging company integrating hardware and software, with full-stack proprietary capabilities in underlying algorithms.

First, Shenzhi Technology possesses an independently developed proprietary underlying algorithm platform for image processing. By leveraging artificial intelligence to enhance image quality, it enables handheld ultrasound devices to achieve imaging capabilities comparable to those of large-scale color Doppler ultrasound systems. Assisted by big data and deep learning, the system processes low-resolution raw ultrasound images to optimize imaging, thereby achieving intelligent segmentation and precise measurement of lesions.

Secondly, Shenzhi Technology adheres to a scenario-driven approach, establishing a standardized workflow for portable ultrasound operations for primary care physicians, thereby enabling the auxiliary diagnostic software to function in both Wi-Fi and offline modes.

Finally, its ASIC chip features high computing power, low power consumption, and strong transferability. By integrating the ASIC chip into handheld ultrasound devices, it is possible to reduce the overall weight of the device and enhance operational smoothness, while embedding more functions directly into the ultrasound system, thereby making portability and ease of use a reality.

Moving forward, Shenzhi Technology will continue to focus on handheld ultrasound, providing solutions for diagnostic needs across diverse scenarios. By turning the possibilities of portability and ease of use into reality, we aim to enhance the operational fluency of ultrasound devices and enable AI-assisted diagnostic software to empower a broader population.